Dr Ecaterina E Dumbrava has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Research or grant funding: Bayer HealthCare Pharmaceuticals Inc, Immunocore LTD, Amgen, Aileron Therapeutics, Compugen Ltd, Gilead, Immunomedics, BOLT Therapeutics, Aprea Therapeutics, Bellicum Pharmaceuticals, PMV Pharma, Triumvira Immunologics, Seagen Inc, Mereo BioPharma 5 Inc, Sanofi, Rain Oncology, Astex Therapeutics, Sotio Biotech, Poseida, Mersana Therapeutics, Genentech, Boehringer Ingelheim, Dragonfly Therapeutics, A2A Pharma, Volastra, AstraZeneca, Modex Therapeutics, Fate Therapeutics, Pfizer